- Home
- LRMR vs AAC Comparison
LRMR vs AAC Comparison
Compare LRMR & AAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LRMR | AAC |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.8M | 497.2M |
| IPO Year | 2014 | 2026 |
Fundamental Metrics
Financial Performance| Metric | LRMR | AAC |
|---|---|---|
| Price | $3.92 | $10.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $16.50 | N/A |
| AVG Volume (30 Days) | ★ 857.9K | 118.4K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,816.14 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.72 | $10.06 |
| 52 Week High | $6.42 | $10.15 |
Technical Indicators
Market Signals| Indicator | LRMR | AAC |
|---|---|---|
| Relative Strength Index (RSI) | 44.77 | N/A |
| Support Level | $3.57 | N/A |
| Resistance Level | $4.21 | N/A |
| Average True Range (ATR) | 0.19 | 0.00 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 20.39 | 0.00 |
Price Performance
Historical ComparisonAbout LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About AAC Ares Acquisition Corporation III Class A Ordinary Shares
Ares Acquisition Corp III is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.